Trump purchased up to $5 million in Axon Enterprise stock while ICE simultaneously pursued a potential $220 million Taser supply deal — Axon manufactures roughly 90% of U.S. Tasers. This timing raises conflict-of-interest questions: Trump's personal financial stake in Axon could benefit from federal purchasing decisions. The deal, if finalized, would more than quadruple ICE's existing Taser inventory, representing a major expansion of stun-weapon procurement under an administration Trump leads.